RecruitingPhase 2ACTRN12605000509662
Gemcitabine and carboplatin induction chemotherapy followed by concurrent cisplatin and IMRT for locally advanced nasopharyngeal cancer
Sponsor
Peter MacCallum Cancer Centre
Enrollment
30 participants
Start Date
Jul 1, 2004
Study Type
Interventional
Conditions
Eligibility
Sex: Both males and females
Inclusion Criteria1
- WHO types 2 and 3 nasopharyngeal cancer; T3-4 and/or N1 > 3 cm, N2-3; no prior malignancies, no prior chemotherapy or radiation
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Induction chemotherapy for 9 weeks followed by concurrent chemoradiation for 7 weeks.
Induction chemotherapy for 9 weeks followed by concurrent chemoradiation for 7 weeks.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12605000509662